61 articles · page 5 of 6
Written by Jeffrey C. Wu, Ph.D. and Brenden S. Gingrich, Ph.D. I. Summary The Supreme Court in Life Technologies Corp. v. Promega Corp. held that providing a single component of a multicomponent invention for manufacture abroad does not give rise to patent…
In Life Technologies Corp. v. Promega Corp. [14-1538] (February 22, 2017), the Supreme Court reversed a Federal Circuit decision that supplying a single component of a multi-component invention from the United States is an infringing act under Patent Act…
Written by Julianna Simon and Jeff van Hoosear On January 18, 2017, the Supreme Court heard oral arguments regarding whether the Lanham Act’s provision refusing federal trademark registration to disparaging marks is invalid under the Free Speech…
Written by Robert J. Hilton, Ph.D. and Jing Liu, Ph.D. On January 13, 2017, the Supreme Court granted certiorari in Amgen v. Sandoz, 794. f. 3d 1347 (Fed. Cir. 2015) and Sandoz v. Amgen, 773 f. 3d 1274 (Fed. Cir. 2014), appealed from the Federal Circuit.…
Written by Jason Jardine and Jane Dai On November 7, 2016, the U.S. Supreme Court declined to review an appeal from a Third Circuit decision finding that a settlement between GlaxoSmithKline (GSK) and Teva Pharmaceutical Industries Ltd. (Teva) involving…
Written by: Jonathan Hyman and Loni L. Morrow The closely watched case of Star Athletica v. Varsity Brands was argued in front of the the Supreme Court on Monday , offering anxious fashion designers a glimpse into how the Justices may rule. As a brief…
Written by Dan Hart, Ph.D. and Jeffrey Wu, Ph.D. I. Overview The Supreme Court recently declined to hear several patent cases, thus leaving the decisions by the Federal Circuit intact. Issues that were not taken up by the Supreme Court include (1) whether…
Obvious Combinations Do Not Need to Be Physically Combinable In Allied Erecting and Dismantling Co., Inc. v. Genesis Attachments, LLC , Appeal No. 2015-1533, the Federal Circuit affirmed the PTAB’s invalidity finding based on obviousness. Genesis…
After two laps through the federal court system, Prometheus has at last received its final verdict from the US Supreme Court: this patent claiming administration of a therapeutic drug and observation of its metabolite levels is invalid for being based on…
Prostate cancer is the most prevalent form of cancer among males, but at present there is no standard test for the disease. It is no wonder, then, that researchers at Johns Hopkins University and several other major universities across the country have…
In Greek mythology, Prometheus stole fire from the Gods and gave it to mankind. In the realm of patents and medical technology, Prometheus Laboratories has turned this myth heralding its namesake’s altruism on its head by stealing the metaphorical…
Does a party who ‘actively induces infringement of a patent’ under 35 U.S.C. §271(b) have to know as a fact that the actions in question support patent infringement? The U.S. Supreme Court granted certiorari in 2010 to Global-Tech…
